291390446	291390446	CD	B-NP	O
|	|	NN	I-NP	O
LOH	LOH	NN	I-NP	O
|	|	NN	I-NP	O
57562672	57562672	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1914398	1914398	CD	B-NP	O
|	|	CC	I-NP	O
9/29/2005	9/29/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-DNA
COPD	COPD	NN	I-NP	I-DNA
flare	flare	NN	I-NP	I-DNA
,	,	,	O	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/10/2005	9/10/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/6/2005	10/6/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
SCARBERRY	SCARBERRY	NN	B-NP	O
,	,	,	O	O
DION	DION	NN	B-NP	O
183-50-47-7	183-50-47-7	CD	I-NP	O
A	A	NNP	I-NP	O
Clearland	Clearland	NNP	I-NP	O
Cale	Cale	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
8/4/05	8/4/05	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
PRASAD	PRASAD	NN	B-NP	O
,	,	,	O	O
AMOS	AMOS	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/14	8/14	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
ELAVIL	ELAVIL	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
AMITRIPTYLINE	AMITRIPTYLINE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QHS	QHS	NNP	I-NP	I-protein
ATENOLOL	ATENOLOL	NNP	I-NP	I-protein
25	25	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/14	8/14	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/19	9/19	CD	I-NP	O
-RRB-	-RRB-	SYM	O	O
GUAIFENESIN	GUAIFENESIN	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
MILLILITERS	MILLILITERS	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/19	9/19	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Other	Other	NNP	I-NP	O
:	:	:	O	O
cough	cough	NN	B-NP	O
OXYCODONE	OXYCODONE	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/19	9/19	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
give	give	VBP	B-VP	O
am	am	NN	B-NP	O
and	and	CC	O	O
pm	pm	NN	B-NP	O
dose	dose	NN	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
morphine	morphine	NN	B-NP	O
.	.	.	O	O

midday	midday	NN	B-NP	O
dose	dose	NN	I-NP	O
2-3pm	2-3pm	NN	I-NP	O
.	.	.	O	O

thank	thank	VB	B-VP	O
you	you	PRP	B-NP	O
.	.	.	O	O

QUININE	QUININE	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
HS	HS	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/19	9/19	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
SENNA	SENNA	NN	I-NP	O
TABLETS	TABLETS	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
SENNOSIDES	SENNOSIDES	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
MVI	MVI	NN	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NN	I-NP	I-protein
MULTIVITAMINS	MULTIVITAMINS	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/2/05	10/2/05	CD	B-NP	O
by	by	IN	B-PP	O
BURKS	BURKS	NNP	B-NP	O
,	,	,	O	O
LEVI	LEVI	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
ZOCOR	ZOCOR	NN	B-NP	B-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
20	20	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/2/05	10/2/05	CD	B-NP	O
by	by	IN	B-PP	O
PITTELKOW	PITTELKOW	NNP	B-NP	O
,	,	,	O	O
TUAN	TUAN	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
MVI	MVI	NN	B-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
71915575	71915575	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
MORPHINE	MORPHINE	NNP	B-NP	O
CONTROLLED	CONTROLLED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
15	15	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q12H	Q12H	NN	I-NP	O
FELODIPINE	FELODIPINE	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
FLONASE	FLONASE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FLUTICASONE	FLUTICASONE	NNP	I-NP	O
NASAL	NASAL	NNP	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
INH	INH	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
ADVAIR	ADVAIR	NN	I-NP	O
DISKUS	DISKUS	IN	B-PP	O
500/50	500/50	CD	B-NP	O
-LRB-	-LRB-	SYM	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
BID	BID	NN	I-NP	O
CALTRATE	CALTRATE	NN	I-NP	O
+	+	SYM	B-NP	O
D	D	NN	I-NP	O
-LRB-	-LRB-	SYM	O	O
CALCIUM	CALCIUM	NN	B-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
600	600	CD	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NNP	I-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
MIX	MIX	NNP	I-NP	O
70/30	70/30	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
70/30	70/30	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
35	35	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
;	;	:	O	O
22	22	CD	B-NP	O
UNITS	UNITS	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
SC	SC	NNP	I-NP	B-protein
35	35	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
QAM	QAM	NNP	I-NP	I-protein
22	22	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
QPM	QPM	NNP	I-NP	I-protein
PREDNISONE	PREDNISONE	NNP	I-NP	I-protein
Taper	Taper	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Give	Give	NNP	I-NP	I-protein
60	60	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
q	q	NN	I-NP	I-protein
24	24	CD	I-NP	I-protein
h	h	NN	I-NP	I-protein
X	X	SYM	B-NP	I-protein
5	5	CD	B-NP	I-protein
dose	dose	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
s	s	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
Give	Give	VB	B-VP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	B-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Starting	Start	VBG	B-VP	O
Today	Today	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/19	9/19	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
COMBIVENT	COMBIVENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
AND	AND	CC	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	O
schedule	schedule	NN	I-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
BCCMC	BCCMC	NN	I-NP	B-protein
early	early	JJ	B-NP	I-protein
next	next	JJ	I-NP	I-protein
week	week	NN	I-NP	I-protein
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Erythromycins	Erythromycin	NNS	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
pneumonia	pneumonia	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
COPD	COPD	NNP	I-NP	O
flare	flare	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
prostate	prostate	NN	I-NP	O
CA	CA	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
R	R	NN	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
recurrent	recurrent	JJ	B-NP	O
pneumothorax	pneumothorax	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
O2	O2	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
OA	OA	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
pain	pain	NN	I-NP	O
BPH	BPH	NN	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
neuopathy	neuopathy	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
cardiac	cardiac	JJ	I-NP	O
MR	MR	NN	I-NP	O
v/q	v/q	NN	I-NP	O
scan	scan	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
--	--	:	O	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Gump	Gump	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
77yo	77yo	CD	I-NP	O
African	African	JJ	I-NP	O
American	American	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
PMH	PMH	NN	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
NIDDM	NIDDM	NN	B-NP	B-protein
and	and	CC	O	O
recent	recent	JJ	B-NP	O
PNA	PNA	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
SHH	SHH	NN	B-NP	O
ED	ED	NN	I-NP	O
on	on	IN	B-PP	O
4/15/05	4/15/05	CD	B-NP	O
via	via	IN	B-PP	O
EMS	EMS	NNP	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
CC	CC	NN	I-NP	O
of	of	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
x	x	SYM	B-NP	O
3d	3d	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
earlier	earlier	RBR	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Dis.ry	Dis.ry	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
diagosed	diagose	VBN	I-VP	O
with	with	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
and	and	CC	O	O
given	give	VBN	B-VP	O
Azithromycin	Azithromycin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admissio	admissio	NN	B-NP	O
he	he	PRP	B-NP	O
said	say	VBD	B-VP	O
his	his	PRP$	B-NP	O
breathing	breathing	NN	I-NP	O
felt	feel	VBD	B-VP	O
more	more	RBR	B-ADJP	O
labored	labor	VBN	I-ADJP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
contacted	contact	VBD	B-VP	O
EMS	EMS	NNP	B-NP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
him	him	PRP	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CHA	CHA	NNP	I-NP	O
ED	ED	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
reported	report	VBD	B-VP	O
worsening	worsen	VBG	I-VP	O
exercise	exercise	NN	B-NP	O
tolerance	tolerance	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
few	few	JJ	I-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
accompanied	accompany	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
20lb	20lb	NN	I-NP	B-protein
weight	weight	NN	I-NP	I-protein
gain	gain	NN	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
noted	note	VBD	B-VP	O
left	left	JJ	B-NP	B-protein
sided	sided	JJ	I-NP	I-protein
pleuritic	pleuritic	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
made	make	VBD	B-VP	O
worse	worse	JJR	B-ADJP	O
by	by	IN	B-PP	O
physical	physical	JJ	B-NP	O
movement	movement	NN	I-NP	O
and	and	CC	O	O
deep	deep	JJ	B-NP	O
breathing	breathing	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
with	with	IN	B-PP	O
supplemental	supplemental	JJ	B-NP	O
O2	O2	NN	I-NP	O
and	and	CC	I-NP	O
Levofloxacin	Levofloxacin	NN	I-NP	O
and	and	CC	O	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
COPD	COPD	NN	B-NP	O
flare	flare	NN	I-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
Home	Home	NN	B-NP	O
meds	med	NNS	I-NP	O
:	:	:	O	O
atenolol	atenolol	NN	B-NP	O
25mg	25mg	NN	I-NP	O
PO	PO	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
HCTZ	HCTZ	NN	B-NP	O
25mg	25mg	NN	I-NP	O
PO	PO	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
felodipine	felodipine	NN	B-NP	O
5mg	5mg	NN	I-NP	O
PO	PO	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
zocor	zocor	NN	B-NP	B-protein
20mg	20mg	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
qhs	qh	NNS	I-NP	I-protein
,	,	,	O	O
ASA	ASA	NNP	B-NP	O
81mg	81mg	NNP	I-NP	O
PO	PO	NNP	I-NP	O
qd	qd	NNP	I-NP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
1	1	CD	I-NP	O
puff	puff	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Combivent	Combivent	NNP	B-NP	O
2	2	CD	I-NP	O
puffs	puff	NNS	I-NP	O
qid	qid	NN	I-NP	O
,	,	,	O	O
loratidine	loratidine	NN	B-NP	O
10mg	10mg	NN	I-NP	O
PO	PO	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
guqifenesin	guqifenesin	NN	B-NP	O
600mg	600mg	NN	I-NP	O
PO	PO	NN	I-NP	O
q12h	q12h	NN	I-NP	O
,	,	,	O	O
morphine	morphine	NN	B-NP	O
15mg	15mg	NN	I-NP	O
PO	PO	NN	I-NP	O
q8-12h	q8-12h	NN	I-NP	O
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
1-2	1-2	CD	I-NP	O
tab	tab	NN	I-NP	O
PO	PO	NN	I-NP	O
q6h	q6h	NN	I-NP	O
,	,	,	O	O
quinine	quinine	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
325mg	325mg	NN	I-NP	O
PO	PO	NN	I-NP	O
qhs	qh	NNS	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100mg	100mg	NNP	I-NP	O
PO	PO	NNP	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Senna	Senna	NNP	B-NP	O
2	2	CD	I-NP	O
tab	tab	NN	I-NP	O
PO	PO	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
+	+	SYM	B-VP	O
vim	vim	NN	B-NP	O
D	D	NN	I-NP	O
125	125	CD	B-NP	O
units	unit	NNS	I-NP	O
PO	PO	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Elavil	Elavil	NNP	B-NP	O
10mg	10mg	CD	I-NP	O
PO	PO	NNP	I-NP	O
qhs	qh	NNS	I-NP	O
--	--	:	O	O
Allergies	Allergy	NNS	B-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	B-protein
--	--	:	O	O
Social	Social	NNP	B-NP	O
Hx	Hx	NNP	I-NP	O
:	:	:	O	O
veteran	veteran	NN	B-NP	O
and	and	CC	O	O
retired	retire	VBD	B-VP	O
school	school	NN	B-NP	O
bus	bus	NN	I-NP	O
driver	driver	NN	I-NP	O
.	.	.	O	O

lives	life	NNS	B-NP	O
with	with	IN	B-PP	O
close	close	JJ	B-NP	O
friend	friend	NN	I-NP	O
in	in	IN	B-PP	O
Thou	Thou	NNP	B-NP	O
son	son	NN	I-NP	O
checks	check	VBZ	B-VP	O
in	in	RP	B-PRT	O
on	on	IN	B-PP	O
him	him	PRP	B-NP	O
multiple	multiple	JJ	B-NP	O
times	time	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
PE	PE	NN	B-NP	O
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
:	:	:	O	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
P	P	NN	B-NP	B-protein
101	101	CD	I-NP	I-protein
,	,	,	O	O
R	R	NN	B-NP	B-protein
28	28	CD	I-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
150/70	150/70	CD	I-NP	I-DNA
,	,	,	O	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
NC	NC	NN	I-NP	O
Pulm	Pulm	NN	I-NP	O
-	-	HYPH	B-VP	O
labored	labor	VBN	B-NP	O
breathing	breathing	NN	I-NP	O
,	,	,	O	O
accessory	accessory	JJ	B-NP	O
muscle	muscle	NN	I-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
rhonchi	rhonchi	NN	B-NP	O
and	and	CC	O	O
expiratory	expiratory	JJ	B-NP	O
wheezes	wheeze	NNS	I-NP	O
present	present	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
both	both	CC	O	O
lung	lung	NN	B-NP	O
fields	field	NNS	I-NP	O
.	.	.	O	O

egophony	egophony	NN	B-NP	O
in	in	IN	B-PP	O
LLL	LLL	NN	B-NP	B-cell_type
.	.	.	O	O

CV	CV	NN	B-NP	O
-	-	HYPH	I-NP	O
normal	normal	JJ	I-NP	O
PMI	PMI	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
RV	RV	NN	I-NP	O
heave	heave	NN	I-NP	O
.	.	.	O	O

RRR	RRR	NN	B-NP	B-protein
.	.	.	O	O

Unable	Unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
appreciate	appreciate	VB	I-VP	O
heart	heart	NN	B-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

weak	weak	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

12cm	12cm	CD	B-NP	O
JVD	JVD	NNP	I-NP	O
.	.	.	O	O

Abd	Abd	NN	B-NP	B-protein
-	-	HYPH	O	O
+	+	SYM	B-NP	O
BS	BS	NN	I-NP	O
,	,	,	O	O
nontender	nontender	JJ	B-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

hepatomegaly	hepatomegaly	RB	B-ADVP	O
.	.	.	O	O

Ext	Ext	NN	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
2	2	CD	I-NP	I-protein
+	+	SYM	I-NP	O
bilateral	bilateral	JJ	I-NP	O
pitting	pitting	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Neuro	Neuro	AFX	B-NP	B-cell_type
-	-	HYPH	I-NP	O
AAOx3	AAOx3	NN	I-NP	B-protein
.	.	.	O	O

CN	CN	NN	B-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

strength	strength	NN	B-NP	O
5/5	5/5	CD	I-NP	O
,	,	,	O	O
symmetric	symmetric	JJ	B-ADJP	O
.	.	.	O	O

unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
elicit	elicit	VB	I-VP	O
reflexes	reflex	NNS	B-NP	O
.	.	.	O	O

--	--	:	O	B-protein
Sig	Sig	NN	B-NP	I-protein
labs	lab	NNS	I-NP	I-protein
and	and	CC	O	O
tests	test	NNS	B-NP	O
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
:	:	:	O	O
BUN	BUN	NN	B-NP	B-DNA
17	17	CD	I-NP	I-DNA
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
1.4	1.4	CD	I-NP	O
,	,	,	O	O
Glucose	Glucose	NN	B-NP	B-protein
179	179	CD	I-NP	I-protein
.	.	.	O	O

WBC	WBC	NNP	B-NP	O
8.7	8.7	CD	I-NP	O
,	,	,	O	O
Hct	Hct	NN	B-NP	B-protein
38	38	CD	I-NP	I-protein
,	,	,	O	O
MCV	MCV	NN	B-NP	O
84	84	CD	I-NP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Albumin	Albumin	NNP	B-NP	O
4.3	4.3	CD	I-NP	O
,	,	,	O	O
Amylast	Amylast	NN	B-NP	B-protein
83	83	CD	I-NP	I-protein
,	,	,	O	O
Lipase	Lipase	NN	B-NP	O
33	33	CD	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
-	-	HYPH	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
old	old	JJ	B-NP	O
RLL	RLL	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
previous	previous	JJ	B-NP	O
tests	test	NNS	I-NP	O
.	.	.	O	O

ECG	ECG	NN	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
nonspecific	nonspecific	JJ	B-NP	O
ST	ST	NN	I-NP	O
changes	change	NNS	I-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
previous	previous	JJ	B-NP	O
tests	test	NNS	I-NP	O
.	.	.	O	O

--	--	:	B-NP	O
Hospital	Hospital	NN	I-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Pulm	Pulm	NN	B-NP	O
-	-	HYPH	I-NP	O
Pt	Pt	NN	I-NP	O
treated	treat	VBN	B-VP	O
for	for	IN	B-PP	O
COPD	COPD	NN	B-NP	O
flare	flare	NN	I-NP	O
with	with	IN	B-PP	O
supplemental	supplemental	JJ	B-NP	O
O2	O2	NN	I-NP	O
,	,	,	O	O
DuoNebs	DuoNeb	NNS	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
steroids	steroid	NNS	B-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
he	he	PRP	B-NP	O
reported	report	VBD	B-VP	O
left	left	JJ	B-NP	O
sided	sided	JJ	I-NP	O
pleuritic	pleuritic	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
evaluated	evaluate	VBD	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
PE	PE	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
V/Q	V/Q	NN	I-NP	O
scan	scan	NN	I-NP	O
that	that	WDT	B-NP	O
reported	report	VBD	B-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
probability	probability	NN	I-NP	O
of	of	IN	B-PP	O
PE	PE	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

CV	CV	NN	B-NP	O
-	-	HYPH	O	O
Pt	Pt	NN	B-NP	O
's	's	POS	B-NP	O
physical	physical	JJ	I-NP	O
exam	exam	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
signs	sign	NNS	B-NP	O
of	of	IN	B-PP	O
right-sided	right-sided	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
notably	notably	RB	B-NP	O
12	12	CD	I-NP	O
cm	cm	NN	I-NP	O
JVD	JVD	NN	I-NP	O
,	,	,	O	O
hepatomegaly	hepatomegaly	NN	B-NP	O
and	and	CC	O	O
later	later	JJ	B-NP	O
hepatojugular	hepatojugular	JJ	I-NP	O
reflex	reflex	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
bilateral	bilateral	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
pitting	pitting	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
proceeded	proceed	VBD	B-VP	O
to	to	TO	I-VP	O
treat	treat	VB	I-VP	O
his	his	PRP$	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
by	by	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
,	,	,	O	O
initially	initially	RB	B-NP	O
PO	PO	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
IV	IV	CD	B-NP	O
.	.	.	O	O

Overall	Overall	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
diuresed	diurese	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
1L	1L	NN	I-NP	O
fluid	fluid	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
further	further	RB	I-VP	O
evaluate	evaluate	VB	I-VP	O
his	his	PRP$	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
MRI	MRI	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
demonstrated	demonstrate	VBN	B-VP	O
normal	normal	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
anatomy	anatomy	NN	I-NP	O
and	and	CC	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
LVEF	LVEF	NN	I-NP	B-protein
was	be	VBD	B-VP	O
73	73	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
valvular	valvular	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

ID	ID	NN	B-NP	O
-	-	HYPH	I-NP	O
Sputum	Sputum	NN	I-NP	O
was	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
few	few	JJ	B-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
cocci	coccus	NNS	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	O	O
suspected	suspect	VBN	B-VP	O
oral	oral	JJ	B-NP	O
flora	flora	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
he	he	PRP	B-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
demonstrate	demonstrate	VB	I-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
WBC	WBC	NNP	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
treat	treat	VB	I-VP	O
with	with	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Endo	Endo	AFX	O	B-protein
-	-	HYPH	O	O
His	His	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Novolog	Novolog	NNP	B-NP	O
.	.	.	O	O

Steroids	Steroid	NNS	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
contributed	contribute	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
elevated	elevated	JJ	I-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
a	a	DT	B-NP	O
previous	previous	JJ	I-NP	O
discharge	discharge	NN	I-NP	O
summary	summary	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
TSH	TSH	NN	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
followed	follow	VBD	B-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
by	by	IN	B-PP	O
rechecking	rechecke	VBG	B-VP	O
his	his	PRP$	B-NP	O
TSH	TSH	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

5	5	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Renal	Renal	JJ	B-ADJP	O
-	-	HYPH	O	O
He	He	PRP	B-NP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
baseline	baseline	NN	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
Cr	Cr	NNP	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
monitored	monitor	VBD	B-VP	O
his	his	PRP$	B-NP	O
Cr	Cr	NN	I-NP	O
and	and	CC	I-NP	O
BUN	BUN	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
the	the	DT	B-NP	O
BUN	BUN	NN	I-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
30s	30	NNS	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
Cr	Cr	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Prophylaxis	Prophylaxis	NN	B-NP	O
-	-	HYPH	I-NP	O
Chronic	Chronic	JJ	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
insomnia	insomnia	NN	I-NP	O
were	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
out-pt	out-pt	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
morphine	morphine	NN	B-NP	O
and	and	CC	I-NP	O
oxycodone	oxycodone	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Elavil	Elavil	NNP	B-NP	O
for	for	IN	B-PP	O
sleep	sleep	NN	B-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
his	his	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cancer	cancer	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
for	for	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
use	use	VB	B-VP	O
your	your	PRP$	B-NP	O
home	home	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
when	when	WRB	B-ADVP	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
sleeping	sleep	VBG	I-VP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
added	add	VBN	I-VP	O
combivent	combivent	JJ	B-NP	O
inhalers	inhaler	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
steroid	steroid	JJ	I-NP	O
taper	taper	NN	I-NP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
medicines	medicine	NNS	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
stop	stop	VB	I-VP	O
the	the	DT	B-NP	O
hydrochlorathiazide	hydrochlorathiazide	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hctz	hctz	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
25mg	25mg	NN	I-NP	O
.	.	.	O	O

Instead	Instead	RB	B-ADVP	O
you	you	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
taking	take	VBG	I-VP	O
lasix	lasix	CD	B-NP	O
20mg	20mg	CD	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
Continue	Continue	NNP	I-NP	O
Lasix	Lasix	NNP	I-NP	O
40mg	40mg	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	I-NP	O
D/C	D/C	NN	I-NP	B-protein
home	home	NN	I-NP	I-protein
HTCZ	HTCZ	NN	I-NP	I-protein
.	.	.	O	O

-	-	HYPH	B-NP	O
Slow	Slow	NN	I-NP	O
Prednisone	Prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
over	over	IN	B-PP	O
next	next	JJ	B-NP	O
20	20	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Have	Have	NN	I-NP	O
PCP	PCP	NN	I-NP	O
address	address	NN	I-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
HTN	HTN	NN	B-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
OSA	OSA	NN	B-NP	O
.	.	.	O	O

Check	Check	NN	B-NP	O
lytes	lyte	NNS	I-NP	O
on	on	IN	B-PP	O
new	new	JJ	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
lasix	lasix	NN	B-NP	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
adding	add	VBG	I-VP	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
considering	consider	VBG	B-VP	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
NIDDM	NIDDM	NN	B-NP	B-protein
.	.	.	O	O

Episodic	Episodic	JJ	B-NP	O
hypoxia	hypoxia	NN	I-NP	O
while	while	IN	B-SBAR	O
sleeping	sleep	VBG	B-VP	O
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
HTN	HTN	NN	I-NP	O
and	and	CC	I-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
observed	observe	VBN	B-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
WEIBEL	WEIBEL	NNP	B-NP	O
,	,	,	O	O
RANDALL	RANDALL	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OU82	OU82	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/4/05	8/4/05	CD	I-NP	O
@	@	SYM	B-NP	O
05	05	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

